Pursuant to Federal regulations (§46.109(e)), an IRB must conduct continuing review of human subjects research at intervals appropriate to the degree of risk, but at least once per year. Research previously approved by the IRB either through expedited procedures or review by the full board is only approved for up to a one-year period from the date of IRB approval. A protocol may be reviewed more frequently than on an annual basis, if the degree of risk warrants and/or if the board has requested to see the protocol on a more frequent basis. Research cannot continue beyond the one-year period without IRB approval.
Note: Exempt Studies do not require Continuing Review submissions.
Please select an IRB below to view IRB specific CR policies and proedures: